Literature DB >> 25559122

Effects on repolarization using dynamic QT interval monitoring in long-QT patients following left cardiac sympathetic denervation.

Christopher V Desimone1, J Martijn Bos2, Katy M Bos3, Jackson J Liang4, Nikhil A Patel5, David O Hodge6, Amit Noheria1, Samuel J Asirvatham1,2, Michael J Ackerman1,2.   

Abstract

BACKGROUND: Videoscopic left cardiac sympathetic denervation (LCSD) is an adjunct therapy for reduction of arrhythmia-induced events in patients with long-QT syndrome (LQTS). LCSD reduces LQTS-triggered breakthrough cardiac events. The temporal effects of QTc changes post-LCSD have not been studied.
METHODS: We utilized continuous QTc monitoring on 72 patients with LQTS. We evaluated acute and long-term QTc changes in comparison to 12-lead ECG-derived QTc values prior to surgery, 24 hours postsurgery, and at follow up ≥3 months.
RESULTS: Seventy-two patients underwent LCSD at our institution (46% male, mean age at LCSD was 14 ± 10 years). The mean baseline, pre-LCSD QTc was 505 ± 56 ms, which had decreased significantly at ≥3 months post-LCSD to 491 ± 40 ms (P = 0.001). QTc monitoring revealed that the majority of the cohort (53/72; 74%) had a transient increase >30 ms in QTc from baseline, with an average maximum increase of 72 ± 30 ms. Resolution within 10 ms of baseline or less occurred in 57% (30/53) at 24 hours post-LCSD.
CONCLUSIONS: Although LQTS patients may have a paradoxically increased QTc post-LCSD, the effects are transient in most patients. Importantly, no patients experienced any arrhythmias in the postoperative setting related to this transient rise in QTc.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ICD; QTc; arrhythmia; left cardiac sympathetic denervation; long-QT syndrome; sudden cardiac death; syncope

Mesh:

Year:  2015        PMID: 25559122      PMCID: PMC4450821          DOI: 10.1111/jce.12609

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  19 in total

1.  Anesthesia for videoscopic left cardiac sympathetic denervation in children with congenital long QT syndrome and catecholaminergic polymorphic ventricular tachycardia--a case series.

Authors:  Christine A Kenyon; Randall Flick; Christopher Moir; Michael J Ackerman; Christina M Pabelick
Journal:  Paediatr Anaesth       Date:  2010-03-22       Impact factor: 2.556

Review 2.  The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy.

Authors:  Peter J Schwartz; Michael J Ackerman
Journal:  Eur Heart J       Date:  2013-03-18       Impact factor: 29.983

3.  Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.

Authors:  Justin M Horner; Masayoshi Kinoshita; Tracy L Webster; Carla M Haglund; Paul A Friedman; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2010-09-17       Impact factor: 6.343

Review 4.  Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

5.  Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome.

Authors:  Mira A Coleman; J Martijn Bos; Jonathan N Johnson; Heidi J Owen; Claude Deschamps; Christopher Moir; Michael J Ackerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-07-11

6.  Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.

Authors:  Peter Nagele; Swatilika Pal; Frank Brown; Jane Blood; J Philipp Miller; Joshua Johnston
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

7.  Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome.

Authors:  Andrew Mathias; Arthur J Moss; Coeli M Lopes; Alon Barsheshet; Scott McNitt; Wojciech Zareba; Jennifer L Robinson; Emanuela H Locati; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Ming Qi; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Li Zhang; Ilan Goldenberg
Journal:  Heart Rhythm       Date:  2013-01-29       Impact factor: 6.343

8.  Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.

Authors:  J Martijn Bos; Katy M Bos; Jonathan N Johnson; Christopher Moir; Michael J Ackerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-05-31

9.  Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.

Authors:  Christopher A Collura; Jonathan N Johnson; Christopher Moir; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2009-03-19       Impact factor: 6.343

10.  Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.

Authors:  Priya Chockalingam; Lia Crotti; Giulia Girardengo; Jonathan N Johnson; Katy M Harris; Jeroen F van der Heijden; Richard N W Hauer; Britt M Beckmann; Carla Spazzolini; Roberto Rordorf; Annika Rydberg; Sally-Ann B Clur; Markus Fischer; Freek van den Heuvel; Stefan Kääb; Nico A Blom; Michael J Ackerman; Peter J Schwartz; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2012-10-17       Impact factor: 24.094

View more
  2 in total

Review 1.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

2.  Renal artery denervation prevents ventricular arrhythmias in long QT rabbit models.

Authors:  An Nu-Khanh Ton; Shin-Huei Liu; Li-Wei Lo; Thien Chuong-Nguyen Khac; Yu-Hui Chou; Wen-Han Cheng; Wei-Lun Lin; Tzu-Yen Peng; Pin-Yi Lin; Shih-Lin Chang; Shih-Ann Chen
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.